MARCKSL1 Antibodies

Santa Cruz Biotechnology offers a broad range of MARCKSL1 monoclonal antibodies for research focused on understanding MARCKSL1 in cellular processes. MARCKSL1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MARCKSL1, or myristoylated alanine-rich C-kinase substrate-like protein 1, plays a crucial role in cellular signaling and cytoskeletal dynamics. MARCKSL1 actively participates in the regulation of cell motility, proliferation, and survival. Research involving MARCKSL1 has significant implications for cancer studies and various other diseases. Understanding MARCKSL1 function continues to reveal new possibilities for therapeutic interventions. Investigating MARCKSL1 expression patterns helps researchers uncover its role in different cellular pathways. MARCKSL1 research contributes to our understanding of fundamental biological processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge and potentially develop new therapeutic strategies.